NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Route 92 Medical

Route 92 Medical

Private
West Jordan, UtahHealthcare & Life Scienceshttps://www.route92medical.com/

Last Round

Series F

Extension

Apr 20, 2026

Total Funding Raised

$229.76M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Route 92 Medical is a medical technology company that develops advanced neurovascular solutions for the treatment of acute ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurovascular interventionischemic stroke treatmentaspiration cathetermechanical thrombectomystroke interventionclot removalneurointerventiondelivery cathetermedical deviceneurovascular deviceclinical trialsinterventional neurologystroke centerneurosurgeon

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Route 92 Medical Comps

Public and private peers based on sector, stage, and business model.

Route 92 Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Route 92 Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series F ExtensionApr 20, 2026
Series FSep 23, 2024
Series FNov 16, 2023
Series EDec 14, 2021
DebtDec 14, 2021
Series D
May 10, 2019

Key People

Founding team and executive leadership

Raj Denhoy

Chief Financial Officer

Executive Team

Kirsten Valley

COO

Executive Team

Route 92 Medical Investors

Notable investors and investment history

Route 92 Medical investors
InvestorRounds
Runway Growth CapitalDebt
The Vertical GroupSeries D, Series E, Series F Extension, Series C, Series A, Series F
InnovaHealth PartnersSeries F Extension, Series F, Series E
U.S. Venture PartnersSeries D, Series E, Series F Extension, Series C, Series A, Series F
Norwest Venture PartnersSeries F Extension, Series F, Series E
Novo HoldingsSeries F Extension, Series F
SectoralSeries F Extension, Series F

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    $50M round completed.

  • Apr 10, 2026

    Moving headquarters to Utah as part of a $5 million expansion and new manufacturing operation.

Route 92 Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Route 92 Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Route 92 Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersWest Jordan, Utah
Employee Range189
Year Founded2015
Last FundingApr 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.